This document is an excerpt from the EUR-Lex website
Document 62019TN0792
Case T-792/19: Action brought on 11 November 2019 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)
Case T-792/19: Action brought on 11 November 2019 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)
Case T-792/19: Action brought on 11 November 2019 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)
OJ C 10, 13.1.2020, p. 50–51
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
13.1.2020 |
EN |
Official Journal of the European Union |
C 10/50 |
Action brought on 11 November 2019 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)
(Case T-792/19)
(2020/C 10/61)
Language in which the application was lodged: German
Parties
Applicant: Agepha Pharma s. r. o. (Senec, Slovakia) (represented by: D. Göbel, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Apogepha Arzneimittel GmbH (Dresden, Germany)
Details of the proceedings before EUIPO
Applicant for the trade mark at issue: Applicant
Trade mark at issue: Application for EU word mark AGEPHA — EU trade mark application No 7 007 909
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 26 August 2019 in Case R 386/2019-2
Form of order sought
The applicant claims that the Court should:
— |
vary the contested decision and reject the opposition; |
— |
in the alternative, annul the contested decision; |
— |
order EUIPO and the other party to pay the costs incurred in the proceedings before the Second Board of Appeal and in the present proceedings. |
Pleas in law
— |
infringement of Article 42(2) of Council Regulation (EC) No 207/2009; |
— |
infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |